{
    "code": "51059003",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51059003",
    "time": "2016-04-22 03:27:47",
    "許可證字號": "衛部藥製字第059003號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/01\/15",
    "發證日期": "105\/01\/15",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105900301",
    "中文品名": "\"台耀\"帕唑帕尼",
    "英文品名": "Pazopanib Hydrochloride \"F.L.\"",
    "適應症": "晚期腎細胞癌之第一線治療，或用於已接受過細胞激素(CYTOKINE)治療失敗之晚期腎細胞癌患者。Pazopanib適用於治療先前曾接受化療的晚期軟組織肉瘤(STS)患者。使用限制: Votrient 對於脂肪細胞型(adipocytic) STS或胃腸道基質瘤(gastrointestinal stromal tumor)的療效尚未獲得證實。",
    "劑型": "041粉劑",
    "包裝": "0.5公斤以上LDPE塑膠袋裝",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "主成分略述": "",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "620102G419  台耀化學股份有限公司",
    "申請商地址": "桃園市蘆竹區和平街36號",
    "主製造廠": {
        "製造廠名稱": "6132051075  台耀化學股份有限公司蘆竹廠",
        "製造廠廠址": "桃園市蘆竹區坑口村和平街36、36-1號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "02059003002-105-03-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059003&Seq=002&Type=8"
        },
        {
            "title": "02059003001-105-03-08.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059003&Seq=001&Type=8"
        }
    ]
}